Attovia Therapeutics (ATTO) holder Alamar HoldCo discloses 3.23M shares, to fall below 10%
Rhea-AI Filing Summary
Alamar HoldCo, LLC reported its initial beneficial ownership in Attovia Therapeutics, Inc. as a more than 10% holder on Form 3. The entity holds 3,229,278 shares of Common Stock directly. The remarks state that, in connection with the closing of Attovia’s initial public offering, Alamar HoldCo will cease to be a 10% holder.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Alamar HoldCo, LLC
Role
10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 3,229,278 shares (Direct)
Key Figures
Common Stock held: 3,229,278 shares
Holder status: More than 10% holder
Form type: Form 3
3 metrics
Common Stock held
3,229,278 shares
Shares of Attovia Common Stock beneficially owned by Alamar HoldCo, LLC following the reported position
Holder status
More than 10% holder
Reporting person status triggering Form 3 filing requirements
Form type
Form 3
Initial statement of beneficial ownership of Attovia equity securities
Key Terms
beneficial ownership, 10% holder, initial public offering
3 terms
beneficial ownership financial
"reported its initial beneficial ownership in Attovia Therapeutics, Inc."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
10% holder regulatory
"the Reporting Entity will cease to be a 10% holder."
initial public offering financial
"In connection with the closing of the Issuer's initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Attovia Therapeutics (ATTO) report in this Form 3 filing?
The filing shows Alamar HoldCo, LLC as a more than 10% beneficial owner of Attovia, holding 3,229,278 Common Stock shares. It is an initial statement of ownership, not a report of new share purchases or sales.
Will Alamar HoldCo, LLC remain a 10% holder of Attovia (ATTO) after the IPO?
The remarks state that, in connection with closing Attovia’s initial public offering, Alamar HoldCo, LLC will cease to be a 10% holder. The filing does not detail the mechanics, only that its ownership percentage will fall below the 10% threshold.
Does this Attovia (ATTO) Form 3 show any insider buying or selling?
No. The Form 3 presents holdings of 3,229,278 Common Stock shares by Alamar HoldCo, LLC but does not report any share purchases, sales, or option exercises. It is a snapshot of ownership, not a transaction report.
Who is identified as the reporting person in Attovia (ATTO)’s Form 3?
The reporting person is Alamar HoldCo, LLC, identified as a more than 10% owner and not as a director or officer. The ownership is reported as direct, meaning the LLC itself holds the disclosed Common Stock shares.